| 05/04/2026 3:19 PM | PERCEPTIVE ADVISORS LLC (1224962) Filed by Trinity Biotech (888721) Subject | Form SCHEDULE 13D/A | |
| 04/08/2026 11:24 AM | O'Caoimh Ronan (1452582) Reporting Trinity Biotech (888721) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/08/2026 5:48 AM | Gillard John (2126172) Reporting Trinity Biotech (888721) Issuer | Form 3/A | |
| 04/03/2026 7:14 AM | Tivnan John Paul (2125530) Reporting Trinity Biotech (888721) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/03/2026 7:15 AM | Murphy Paul (2126174) Reporting Trinity Biotech (888721) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/03/2026 7:09 AM | Omidvar Andrew (2126105) Reporting Trinity Biotech (888721) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/03/2026 7:11 AM | Gillard John (2126172) Reporting Trinity Biotech (888721) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/25/2026 8:12 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/16/2026 10:32 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/10/2026 7:01 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/10/2026 7:07 AM | Trinity Biotech (888721) Filer | Form 424B3 | |
Get the Latest News and Ratings for TRIB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/10/2026 7:10 AM | Trinity Biotech (888721) Filer | Form 424B3 | |
| 03/10/2026 6:50 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/03/2026 11:15 PM | Trinity Biotech (888721) Filer | Form EFFECT | |
| 02/25/2026 11:00 AM | Trinity Biotech (888721) Filer | Form 424B3 | |
| 02/25/2026 8:10 AM | Trinity Biotech (888721) Filer | Form F-1 Registration statement for securities of certain foreign private issuers | |
| 02/25/2026 8:00 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/20/2026 4:15 PM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/17/2026 5:09 AM | Trinity Biotech (888721) Filer | Form 424B3 | |
| 02/13/2026 2:18 PM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/26/2026 4:19 PM | PERCEPTIVE ADVISORS LLC (1224962) Filed by Trinity Biotech (888721) Subject | Form SCHEDULE 13D/A | |
| 01/25/2026 11:15 PM | Trinity Biotech (888721) Filer | Form EFFECT | |
| 01/23/2026 4:14 PM | Trinity Biotech (888721) Filer | Form 424B3 | |
| 01/15/2026 3:27 PM | Trinity Biotech (888721) Filer | Form F-1 Registration statement for securities of certain foreign private issuers | |
| 12/23/2025 3:49 PM | PERCEPTIVE ADVISORS LLC (1224962) Filed by Trinity Biotech (888721) Subject | Form SCHEDULE 13D/A | |
| 12/23/2025 7:55 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/23/2025 6:40 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/23/2025 6:31 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/18/2025 12:34 PM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/15/2025 8:16 PM | DAYLI Partners, Inc. (2101262) Filed by Trinity Biotech (888721) Subject | Form SCHEDULE 13D/A | |
| 12/10/2025 7:51 PM | MiCo IVD Holdings, LLC (1952094) Filed by Trinity Biotech (888721) Subject | Form SCHEDULE 13D/A | |
| 12/04/2025 7:27 PM | MiCo IVD Holdings, LLC (1952094) Filed by Trinity Biotech (888721) Subject | Form SCHEDULE 13D/A | |
| 11/21/2025 9:02 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 10:30 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/24/2025 6:30 PM | PERCEPTIVE ADVISORS LLC (1224962) Filed by Trinity Biotech (888721) Subject | Form SCHEDULE 13D/A | |
| 10/23/2025 3:32 PM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/30/2025 3:00 PM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/08/2025 5:03 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/02/2025 1:17 PM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/20/2025 1:18 PM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/15/2025 9:24 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
| 08/12/2025 3:33 PM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/08/2025 5:00 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/24/2025 1:38 PM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/01/2025 9:27 AM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/24/2025 2:03 PM | Trinity Biotech (888721) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |